**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 150-76-5 |4-Methoxyphenol | 99% | 205-769-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22 36 43
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Irritating to eyes. May cause sensitization by
skin contact.Hygroscopic (absorbs moisture from the air).Mutagen.
Potential Health Effects
Eye:
Causes eye irritation. May result in corneal injury. May cause
eye burns. May cause eye injury. Causes redness and pain.
Skin:
Harmful if absorbed through the skin. May be absorbed through
damaged or abraded skin in harmful amounts. May cause skin burns.
May cause reddening of the skin. If absorbed, may cause central
nervous system effects. May cause depigmentation of the skin.
Produces primary irritant dermatitis, sensitization dermatitis, and
skin ulcerations.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
May cause liver damage. May form methemoglobin which in sufficient
concentration causes cyanosis (bluish discoloration of skin due to
deficient oxygenation of the blood). May cause necrotic changes in
the gastrointestinal tract.
Inhalation:
May cause irritation of the respiratory tract with burning pain in
the nose and throat, coughing, wheezing, shortness of breath and
pulmonary edema. May cause cardiac abnormalities. Harmful if
inhaled.
Chronic:
May cause liver and kidney damage. Chronic exposure may cause visual
disturbances. Laboratory experiments have resulted in mutagenic
effects. Prolonged or repeated contact may cause possible eczema.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing
is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. This
material in sufficient quantity and reduced particle size is capable
of creating a dust explosion.
Extinguishing Media:
Use water fog, dry chemical, carbon dioxide, or regular foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up or absorb material, then place into a
suitable clean, dry, closed container for disposal. Avoid generating
dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use only in a well-ventilated area.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Store protected from light and air.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 150-76-5:
Belgium - TWA: 5 mg/m3 VLE
France - VME: 5 mg/m3 VME
Germany: 5 mg/m3 TWA
Malaysia: 5 mg/m3 TWA
Netherlands: 5 mg/m3 MAC
Spain: 5 mg/m3 VLA-ED
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: white
Odor: phenol-like
pH: Not available.
Vapor Pressure: < 0.01 mm Hg @20C
Viscosity: 8.5 cP 65 deg C
Boiling Point: 243 deg C @ 760.00mm Hg
Freezing/Melting Point: 54 deg C
Autoignition Temperature: 421 deg C ( 789.80 deg F)
Flash Point: 133 deg C ( 271.40 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density: 1.55 @ 20 deg C/20C
Molecular Formula: C7H8O2
Molecular Weight: 124.14
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Light, dust generation, excess heat, exposure to moist air or water.
Incompatibilities with Other Materials:
Acid anhydrides, acid chlorides, bases, oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, phenol.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 150-76-5: SL7700000
LD50/LC50:
CAS# 150-76-5: Draize test, rabbit, skin: 6 gm/12D (Intermittent)
Mild; Draize test, rabbit, skin: 10%; Oral, rat: LD50 = 1600 mg/kg.
ORAL LD 50 (RAT):
Carcinogenicity:
4-Methoxyphenol -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Ecotoxicity:
Fish: Goldfish: +/-200 mg/L; 48 hrs; LC50Fish: Fathead Minnow: 140
mg/L; 96 hrs; LC50:flowthrough bioassay
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 36 Irritating to eyes.
R 43 May cause sensitization by skin contact.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
S 46 If swallowed, seek medical advice immediately
and show this container or label.
WGK (Water Danger/Protection)
CAS# 150-76-5: 1
Canada
CAS# 150-76-5 is listed on Canada's DSL List.
CAS# 150-76-5 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 150-76-5 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 2/04/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
3'-Aminoacetophenone, 97%
| 99-03-6 |
|
8-Azaguanine, 98%
| 134-58-7 |
|
N,N-Dimethyl-p-phenylenediamine oxalate, 99% (titr.)
| 62778-12-5 |
|
4-Ethoxy-2-Buten-1-ol, 98% (Mixt. Cis and Trans Isomers)
| 123093-78-7 |
|
Decanoyl Chloride, 98%
| 112-13-0 |
|
N,N'-Bis(3-Aminopropyl)-1,3-Propane- Diamine, 97% (Titr.)
| 4605-14-5 |
|
2,3-Bis-(Bromomethyl)Quinoxaline, 98%
| 3138-86-1 |
|
4-N-propylbiphenyl-4'-carboxylic acid, 98%
| 88038-94-2 |
|
4-Nitrobenzoyl chloride, 98%
| 122-04-3 |
|
N,N,N',N'-Tetrakis(2-hydroxyethyl)ethylenediamine, 99% (titr.)
| 140-07-8 |
|
2-(4-Carboxyphenoxy)-2-Pivaloyl-2',4'-Dichloroacetanilide, 96% (HPLC)
| 58161-93-6 |
|
Ethyl 7-nitroindole-2-carboxylate, 95+%
| 6960-46-9 |
|
Cyclohexanecarboxylic Acid Chloride, 98% by Titration
| 2719-27-9 |
|
Gadolinium atomic absorption standard solution, 1 mg/ml Gd in 2% HNO3
| 7440-54-2 |
|
trans-1,2-Dichlorocyclohexane, 97%
| 822-86-6 |
|
Ethyl 4-fluorobenzoate ,99%
| 451-46-7 |
|
4-Aminophenyl ether, 98%
| 101-80-4 |
|
Dodecylthioacetonitrile, 92% (GC)
| 51956-42-4 |
|
Cyclopropyl bromide, 99%
| 4333-56-6 |
|
Hydrogenhexahydroxyplatinate (IV), ca. 64% Pt
| 51850-20-5 |
|
Trimethyl-1,5,9-Cyclododecatriene (Mixture of Isomers), 98%
| 27193-69-7 |
|
4,4'-Diamino-2,2'-biphenyldisulfonic acid (techn), 85% (titr.)
| 117-61-3 |
|
Valeramide
| 626-97-1 |
|
4-(Chloromethyl)-3,5-Dimethyl-Isoxazole 98%
| 19788-37-5 |
|
1,2,4-Trimethylbenzene, 98%
| 95-63-6 |
|
Sec-Butyl Disulfide, 98%
| 593-30-6 |
|
Platinum(ii) chloride, 73% pt
| 10025-65-7 |
|
8-Azahypoxanthine, 98%
| 2683-90-1 |
|
(2-Bromoethyl)-Trimethylammonium Bromide, 98%
| 2758-06-7 |
|
3',5'-Dihydroxyacetophenone, 97%
| 51863-60-6 |
|
4,5-Dimethoxy-2-Mercapto-Benzylamine Hydrochloride, 92%
| 21407-29-4 |
|
4-Amino-2-methylmercaptoquinazoline
| 63963-40-6 |
|
Z-1,3-Dichloropropene
| 542-75-6 |
|
4-Fluorosulfonyl-1-hydroxy-2-naphthoic acid, 99%
| 839-78-1 |
|
Tris(2-ethylhexyl)trimellitate, 98%
| 3319-31-1 |
|
4-Methoxyphenol, 99%
| 150-76-5 |
|
Rose bengal, high purity biological stain
| 632-69-9 |
|
Thionicotinamide, 99%
| 4621-66-3 |
|
Magnesium iodate tetrahydrate, 98%
| 0-00-1 |
|
Harmaline hydrochloride dihydrate
| 6027-98-1 |
|
Trans-Aconitic Acid, 98%
| 4023-65-8 |
|
3,4-Dichlorobenzophenone, 99%
| 6284-79-3 |
|
1,4-Dichloro-2,3-butanediol, mixture of DL- and meso, 99.0%
| 2419-73-0 |
|
Di-n-octadecyl phosphite, 95% c18, (gc)
| 19047-85-9 |
|
Aza-12-Crown-4, 99.5+%
| 41775-76-2 |
|
4-Isopropylaniline, 99%
| 99-88-7 |
|
sec-Butylbenzene, 99+%
| 135-98-8 |
|
Ethyl Carbanilate
| 101-99-5 |
|
2-Chloronicotinic Acid, 98%
| 2942-59-8 |
|
2-Bromoacetamide, 98%
| 683-57-8 |
|
|